×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
6923 views

Moderators : Anna Fagotti & Gwenaël Ferron

Agenda

  Introduction
Anna Fagotti & Gwenaël Ferron
 
  HIPEC in first setting
Willemien Van Driel
 
  HIPEC in recurrent disease
Jean-Marc Classe
 
  Oncologic issues
Laurence Gladieff
 
  Take home message
Anna Fagotti
 

 

Shooting date : 2024-02-06
Last update : 2024-04-03
2 comments
Join the Discussion
  • ANIK G. Can't wait to see this webinar. Wonderful and much anticipated topic.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Gwenaël F. Dear Anik. The VOD is available !!

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
      Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
      San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
      New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
      Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
      London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
      Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
      Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
      Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
      Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
      Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
      Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
      Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
      Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

      Prise en charge des cancers de l'ovaire en rechute :

      état des lieux et perspectives

      Share
      Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
      Honolulu : Tuesday, April 12th 2022 from 06am to 07:30am (GMT+2)
      San Francisco : Tuesday, April 12th 2022 from 09am to 10:30am (GMT+2)
      New York : Tuesday, April 12th 2022 from 12pm to 01:30pm (GMT+2)
      Buenos Aires : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT+2)
      Reykjavik : Tuesday, April 12th 2022 from 04pm to 05:30pm (GMT+2)
      London / Dublin : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+2)
      Paris / Berlin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
      Istanbul : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+2)
      Moscou / Dubaï : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+2)
      Bangkok : Tuesday, April 12th 2022 from 11pm to 12:30am (GMT+2)
      Shanghai : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+2)
      Tokyo : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+2)
      Sydney : Wednesday, April 13th 2022 from 03am to 04:30am (GMT+2)
      Wellington : Wednesday, April 13th 2022 from 05am to 06:30am (GMT+2)

      Cancers séreux de bas grade

      Share
      Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
      Honolulu : Tuesday, October 18th 2022 from 06am to 07:30am (GMT+2)
      San Francisco : Tuesday, October 18th 2022 from 09am to 10:30am (GMT+2)
      New York : Tuesday, October 18th 2022 from 12pm to 01:30pm (GMT+2)
      Buenos Aires : Tuesday, October 18th 2022 from 01pm to 02:30pm (GMT+2)
      Reykjavik : Tuesday, October 18th 2022 from 04pm to 05:30pm (GMT+2)
      London / Dublin : Tuesday, October 18th 2022 from 05pm to 06:30pm (GMT+2)
      Paris / Berlin : Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
      Istanbul : Tuesday, October 18th 2022 from 07pm to 08:30pm (GMT+2)
      Moscou / Dubaï : Tuesday, October 18th 2022 from 08pm to 09:30pm (GMT+2)
      Bangkok : Tuesday, October 18th 2022 from 11pm to 12:30am (GMT+2)
      Shanghai : Wednesday, October 19th 2022 from 12am to 01:30am (GMT+2)
      Tokyo : Wednesday, October 19th 2022 from 01am to 02:30am (GMT+2)
      Sydney : Wednesday, October 19th 2022 from 03am to 04:30am (GMT+2)
      Wellington : Wednesday, October 19th 2022 from 05am to 06:30am (GMT+2)

      Evolution de la chirurgie du cancer de l’ovaire en 2022

      Share
      Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
      Honolulu : Tuesday, November 21st 2023 from 06am to 07:30am (GMT+1)
      San Francisco : Tuesday, November 21st 2023 from 08am to 09:30am (GMT+1)
      New York : Tuesday, November 21st 2023 from 11am to 12:30pm (GMT+1)
      Buenos Aires : Tuesday, November 21st 2023 from 01pm to 02:30pm (GMT+1)
      London / Dublin : Tuesday, November 21st 2023 from 04pm to 05:30pm (GMT+1)
      Paris / Berlin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
      Istanbul : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
      Moscou / Dubaï : Tuesday, November 21st 2023 from 08pm to 09:30pm (GMT+1)
      Bangkok : Tuesday, November 21st 2023 from 11pm to 12:30am (GMT+1)
      Shanghai : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
      Tokyo : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
      Sydney : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
      Wellington : Wednesday, November 22nd 2023 from 04am to 05:30am (GMT+1)

      Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

      Share
      Scroll Up